Skip to content

TransMedics Group, Inc. TMDX Net Investment in Lease

Net Investment in Lease at other companies

LivaNova logo
LivaNovaLIVN
ICU Medical logo
ICU MedicalICUI
Edwards Lifesciences logo
Edwards LifesciencesEW

Other financials

Income statement

See full
Revenue$173.9M+21.2%
Gross profit$101.2M+14.7%
Operating income$13.3M-51.5%
Net income$7.3M-71.5%
EPS (diluted)$0.20-71.4%

Balance sheet

See full
Cash & equivalents$461.7M+48.9%
Total debt$409.9M+505%
Total equity$494.0M+85.5%
Total assets$1.4B+71.3%

Cash flow

See full
Operating cash flow$24.5M+959%
CapEx$36.7M+35.6%
Free cash flow-$12.1M+59.4%

Valuation

See full
Market cap$2.55B+50.6%
Enterprise value$2.5B+66.0%
P/E14.8×-19.8×
P/S+0.5×

Profitability

See full
Gross margin59.1%-0.4pp
Operating margin14.9%+4.1pp
Net margin27%+17.0pp
FCF margin23.8%

Returns & leverage

See full
Return on equity45.2%+22.2pp
Debt / equity0.8×+0.6×
Current ratio6.7×-2.4×

Where this comes from

Reported directly by TransMedics Group, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The official record: TransMedics Group, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about TransMedics Group, Inc.'s net investment in lease.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is TransMedics Group, Inc.'s net investment in lease?
TransMedics Group, Inc. (TMDX) reported net investment in lease of $4.86M in Q1 2026.
How has TransMedics Group, Inc.'s net investment in lease changed year-over-year?
TransMedics Group, Inc.'s net investment in lease decreased by 19.1% year-over-year, from $6.01M to $4.86M.
What is the long-term trend for TransMedics Group, Inc.'s net investment in lease?
Over 4 years (2021 to 2025), TransMedics Group, Inc.'s net investment in lease has grown at a -3.1% compound annual growth rate (CAGR), from $5.85M to $5.16M.